Myriad Genetics Inc (NASDAQ:MYGN)
| 15.49 Delayed Data As of Jun 03 |  +0.11 / +0.71%Today’s Change | 9.24 Today|||52-Week Range 48.40 | -43.11% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Capone Mark C President & Chief Executive Officer |  Sale | 8/01/2019 | 70,672 | $44.00 | $3.1M | -65.56% |
Capone Mark C President & Chief Executive Officer | Sale | 8/01/2019 | 58,138 | $44.00 | $2.6M | -65.56% |
Capone Mark C President & Chief Executive Officer |  Buy | 8/01/2019 | 58,138 | $30.34 | $1.8M | -65.56% |
Capone Mark C President & Chief Executive Officer | Buy | 8/01/2019 | 70,672 | $23.11 | $1.6M | -65.56% |
King Gary A /myriad/ Executive Vice President | Sale | 8/01/2019 | 30,000 | $46.19 | $1.4M | -65.56% |
Riggsbee R Bryan Chief Financial Officer | Sale | 8/01/2019 | 25,000 | $41.50 | $1.0M | -65.56% |
King Gary A /myriad/ Executive Vice President | Buy | 8/01/2019 | 30,000 | $26.49 | $794.7K | -65.56% |
King Gary A /myriad/ Executive Vice President | Sale | 8/01/2019 | 20,000 | $39.44 | $788.8K | -65.56% |
Capone Mark C President & Chief Executive Officer | Sale | 9/30/2019 | 18,295 | $28.63 | $523.8K | -45.86% |
Tobin Bernard | Sale | 8/01/2019 | 11,712 | $40.00 | $468.5K | -65.56% |
Page of 5